Tweet
Discov Med. 2014 Dec;18(101):313-22.
The contribution of non-human primate models to the development of human vaccines.
Rivera-Hernandez T1, Carnathan DG2, Moyle PM3, Toth I4, West NP1, Young PR1, Silvestri G2, Walker MJ1.
Author information
Abstract
The non-human primates (NHPs) model in biomedical research has contributed to the study of human infectious, autoimmune, oncogenic, and neurological diseases. This review focuses on the importance of NHP models in vaccine development for tuberculosis, pertussis, Dengue, group A streptococcus (Streptococcus pyogenes) infection, HIV infection, and certain diseases in the elderly (influenza, for example). From understanding disease pathogenesis and mechanisms of protection, to assessing vaccine safety and efficacy, we discuss selected cases where the importance of the use of NHP models is highlighted.
PMID: 25549702 [PubMed - in process]
The contribution of non-human primate models to the development of human vaccines.
Rivera-Hernandez T1, Carnathan DG2, Moyle PM3, Toth I4, West NP1, Young PR1, Silvestri G2, Walker MJ1.
Author information
Abstract
The non-human primates (NHPs) model in biomedical research has contributed to the study of human infectious, autoimmune, oncogenic, and neurological diseases. This review focuses on the importance of NHP models in vaccine development for tuberculosis, pertussis, Dengue, group A streptococcus (Streptococcus pyogenes) infection, HIV infection, and certain diseases in the elderly (influenza, for example). From understanding disease pathogenesis and mechanisms of protection, to assessing vaccine safety and efficacy, we discuss selected cases where the importance of the use of NHP models is highlighted.
PMID: 25549702 [PubMed - in process]
